Kazuko Kaneda

Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype

K. Koike, S. Furuta, T. Kamata, 2015, Journal of Virology.

Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56

Y. Saito, H. Itoh, I. Miura, 2013, Leukemia.

Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma

T. Watabe, E. Shimosegawa, K. Kabayama, 2023, The Journal of Nuclear Medicine.

CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression

Y. Saito, S. Nakahata, K. Morishita, 2011, Leukemia.

Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1).

Y. Kanai, S. Nagamori, Yoko Tanaka, 2017, Journal of pharmacological sciences.

Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation

Y. Saito, S. Nakahata, K. Morishita, 2011, Oncogene.

The Increased Expression of Integrin α6 (ITGA6) Enhances Drug Resistance in EVI1high Leukemia

Kazuhiro Morishita, K. Morishita, Yusuke Saito, 2012, PloS one.

Synthesis of [211At]4-astato-L-phenylalanine by dihydroxyboryl-astatine substitution reaction in aqueous solution

T. Watabe, E. Shimosegawa, J. Hatazawa, 2021, Scientific Reports.